MedPath

PORTRAZZA

PORTRAZZA

Discontinued
DIN Number

02462478

Drug Class

Human

Market Date

N/A

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02462478
AIG Number0158910001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FE03 NECITUMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NECITUMUMABActive
Strength: 16 MG / ML
Monograph: NECITUMUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.